当前位置: 首页 > 期刊 > 《中国药房》 > 202021
编号:13793832
老年多重用药研究现状与热点前沿的文献计量学分析(6)
http://www.100md.com 2020年11月1日 《中国药房》 202021
     [26] KHEZRIAN M,MCNEIL CJ,MURRAY AD,et al. An overview of prevalence,determinants and health outcomes of polypharmacy[J]. Ther Adv Drug Saf,2020. DOI:10.1177/2042098620933741.

    [27] WALCKIERS D,VAN DER HEYDEN J,TAFFOREAU J. Factors associated with excessive polypharmacy in ol- der people[J]. Arch of Public Health,2015. DOI:10.1186/s13690-015-0095-7.

    [28] JYRKKA J,ENLUND H,KORHONEN MJ,et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons results of the Kuopio 75+study:a cross-sectional analysis[J]. Drugs Aging,2009,26(6):493-503.

    [29] JUNIUS-WALKER U,THEILE G,HUMMERS-PRADIER E. Prevalence and predictors of polypharmacy among older primary care patients in Germany[J]. Fam Pract,2007,24(1):14-19.

    [30] CASHION W,MCCLELLAN W,HOWARD G,et al. Geographic region and racial variations in polypharmacy in the United States[J]. Ann Epidemiol,2015,25(6):433-438.

    [31] PATTERSON SM,HUGHES C,KERSE N,et al. Interventions to improve the appropriate use of polypharmacy for older people[J]. Cochrane Database Syst Rev,2012. DOI:10.1002/14651858.CD008165.pub4.

    [32] 趙丽艳,赵忠鹏,程艳芹,等.老年人不适当用药的研究进展[J].中国医药导报,2019,16(21):47-50.

    (收稿日期:2020-07-17 修回日期:2020-08-17)

    (编辑:刘明伟), 百拇医药(渠吉皊 沈易静 周婷 刘永兵)
上一页1 2 3 4 5 6